Developing new anti-cancer treatments is expensive, and national, public funding organisations across Europe dedicate substantial resources to this task. Linking their research programmes helps to ensure these funds are used to best effect. The ERA-Net Transcan is now continuing as the ERA-Net Cofund Transcan-2 network, fostering long-term transnational research synergy.
© cacaroot - fotolia.com
Updated on 29 March 2018
Transcan was set up in 2011 by public funding organisations supporting translational cancer research research that aims to develop promising scientific leads into new ways of predicting, detecting and treating cancer. It spanned 16 EU countries as well as Israel, Norway and Turkey. The partners, including several well-known cancer charities, funded 30 projects with a total of €33 million from national research budgets. Projects focused on various aspects of cancer prevention as well as biomarkers that enable personalised medicine.
Transcan-2 continues to foster coherence and synergies among the participants national and charity funding programmes. Based on an analysis of research needs and opportunities, it has issued four calls for proposals,and so far funded 37 projects, worth € 35 million, to advance work in selected priority areas. Since 2011, these calls have been supported by the EU with a total of €8.6 million.
A first call, which closed in 2015, focused on the differences among tumours in terms of response to therapy and potential recurrence. The second and third calls were dedicated to immune system-based cancer therapy and non- or minimally-invasive methods for the early detection and/or progression of cancer. A fourth call, on rare cancers, is under evaluation.
Further work in Transcan-2 will be aimed at developing strategies to extend the network, enhance its coordination and ensure efficient dissemination of outcomes conducted both by the consortium and funded projects. In addition, partners will be monitoring projects' contents and performing a critical assessment of their combined programme.